Renerve
- Short interest
- 0.00%
- as of 6 May 2025
- Reported shorts
- 1.4K
- Shares on issue
- 109.448M
Renerve (RNV) Short Interest
Renerve (ASX:RNV) had 0.00% of shares reported as short positions as of 6 May 2025, representing 1,358 shares. Renerve operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4About Renerve
Renerve is an Australian company in the Health Care Equipment & Services industry, focusing on medical technology. Without further information, a detailed summary of its business model, market position, and unique value proposition cannot be provided.
Company profile →Renerve (ASX:RNV) has 0.00% of its shares on issue reported as short positions as of 6 May 2025, or about 1,358 shares. RNV is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads RNV today
- Zanger BreakoutWatchScore 30rank 625 of 1942
- CAN SLIMWatchScore 10rank 1130 of 1541
- Minervini Trend TemplateWatchScore 7rank 1546 of 1716
- Crowded-Short BreakoutWatchScore 9rank 1185 of 1500
- Quality compoundersWatchScore 25rank 573 of 1669
Prices to 14 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
RNV fundamentals
In the year to 30 Jun 2026, Renerve (ASX:RNV) recorded revenue of A$510.4K and a net loss after tax of A$5.6M. A year earlier it recorded revenue of A$271.7K and a net loss after tax of A$3.7M. Year-on-year growth: revenue +87.8% (FY). Net margin −1,091.9%, return on equity −133.1% (FY). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 14 Oct 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest RNV news
All news- Positive FDA Feedback on NervAlign Nerve Guide Matrix
asx · 13 Oct 2026
- Change of Director's Interest Notice - P Savage
asx · 5 Oct 2026
- Change of Director's Interest Notice - M McGuire
asx · 5 Oct 2026
Company details
Company information is being updated. Check back soon.
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss RNV
Start a research thread or post the first pulse update